← Back to Search

INVEST for Vaccine Hesitancy (INVEST Trial)

N/A

Waitlist Available

Led By Emmanuel Walter, MD, MPH

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

- Any public middle school in Cherokee County, South Carolina or Rockingham County, North Carolina school district

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months

Awards & highlights

INVEST Trial Summary

This trial will test a school-based intervention for increasing vaccination rates among rural adolescents in North and South Carolina.

INVEST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

INVEST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the proportion of adolescents who ever received at least one dose of HPV vaccination in the intervention group after the intervention implementation compared with before intervention implementation

Secondary outcome measures

Change in the proportion of adolescents who have completed the HPV vaccination series (2 or 3 doses depending on age at vaccination initiation) in the intervention group after implementation compared with before intervention implementation

Mean score representing fidelity of intervention across intervention schools.

INVEST Trial Design

1Treatment groups

Experimental Treatment

Group I: INVEST InterventionExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,358 Previous Clinical Trials

3,418,833 Total Patients Enrolled

2 Trials studying Vaccine Hesitancy

791 Patients Enrolled for Vaccine Hesitancy

University of South CarolinaOTHER

211 Previous Clinical Trials

119,223 Total Patients Enrolled

Emmanuel Walter, MD, MPHPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people being recruited for this experiment right now?

"This clinical trial, which was active from 8/31/2021 to 9/1/2022 according to the listing on clinicaltrials.gov is no longer enrolling new participants. Although this research has concluded, there are other studies that are still looking for volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Increase Vaccine Uptake in Adolescent in Rural South

2021. "Increase Vaccine Uptake in Adolescent in Rural South". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04999267.